Why Midlife Women Feel Like They're Losing Their Cognitive Edge

By Hanah Polotsky, MD | Board-Certified Endocrinologist | OpExMD

The high-performing woman arrives, not frantic, but organized. She presents her list with precision:

“I’m not thinking as fast.”

“I lose my train of thought mid-sentence.”

“I reread emails three times before sending them.”

And almost an aside: “I wake up at 3 AM. Not anxious. Just awake.”

Nothing external has changed, same high-level job, the same woman who has operated at this pace for fifteen years. Yet, something is undeniably wrong. She asks the question quietly, "Is something wrong with me?"

The answer is: Nothing is wrong with you. But something is changing, and it is physiological, not psychological.

Most women receive a variation of: you're stressed, your labs are normal, it's just part of getting older. While not entirely incorrect, these dismissals fail to explain the actual coordinated physiologic transition underway, a shift that is not visible on standard lab work.

The Science Behind the Shift

The core driver is hormonal fluctuation, primarily estrogen. Estrogen is not solely a reproductive hormone; it is highly active in the prefrontal cortex and hippocampus, the brain regions that manage processing speed, word retrieval, and executive function. When estrogen levels fluctuate, not just decline, cognitive efficiency changes.

A 2022 International Menopause Society white paper documented measurable, modest but real shifts in verbal learning and memory across the menopausal transition. This is not dementia; it is a physiologic shift influenced by the interplay of sleep, metabolic instability, and hormonal variability. The most affected cognitive domains are verbal learning, verbal memory, and processing speed, with subsequent impact on working memory, attention, and executive function.

Crucially, research shows that the period of fluctuation (perimenopause) is the most disruptive phase. Perimenopausal women show poorer cognitive outcomes than premenopausal women, while postmenopausal women often stabilize. This explains why the complaint is so sharp in the years leading up to menopause, and why standard chronological age-based assessments miss the experience.

The Compounding Factors

The transition rarely involves a single mechanism; the burden is additive, creating a depleted system:

Disrupted Sleep

Sleep disruption is often the first change noticed, like waking at 3 or 4 AM. Declining estrogen contributes to sleep-fragmenting hot flashes and night sweats, while the withdrawal of progesterone impairs sleep depth and continuity. Progesterone's sedative and sleep-stabilizing effects rely on modulating GABA-A receptors. Its postmenopausal withdrawal is directly linked to disrupted sleep architecture and reduced slow-wave sleep, even independent of hot flashes, driven by low estradiol and elevated FSH. Fragmented sleep degrades the brain's ability to consolidate memory, restore emotional regulation, and rebuild decision-making capacity. It fundamentally changes how you think.

Underrated Vasomotor Symptoms

Hot flashes and night sweats (vasomotor symptoms) are frequently minimized, even by the women experiencing them. However, objective physiologic monitoring has shown that vasomotor symptoms, particularly those occurring during sleep, are associated with poorer verbal memory performance, independent of the woman’s subjective sleep complaint. Neuroimaging supports this, showing that a higher physiologic burden of vasomotor symptoms is associated with altered function in the hippocampus and prefrontal cortex during memory tasks.

Metabolic Instability

Estrogen interacts closely with insulin sensitivity. As hormonal patterns shift, metabolic changes that predispose to insulin resistance develop, often before routine labs register an abnormality. Estrogen withdrawal reduces insulin sensitivity, impacting brain energy metabolism. The brain requires stable energy delivery, and disruptions lead to changes in mental endurance, afternoon crashes, a shorter attention span, and a sense of cognitive depletion that did not exist in her 30s. Substantial brain remodeling, such as changes in structure, connectivity, glucose metabolism, and ATP production, occurs during perimenopause, contributing to neurological symptoms long before any structural change is detectable.

Narrowed Stress Recovery Margin

High-performing women often report a narrower margin for stress recovery. While the research here is preliminary, the compounding effect of fragmented sleep, hormonal variability, and metabolic instability narrows the physiologic buffer these women rely on. The system simply has less reserve capacity. This is a physiologic reality, not a character flaw or a stress management problem.

The Cost of Compensation

The women presenting with these symptoms are almost always high performers who are experts at compensation. They prepare more, double-check more, and push through. The SWAN study confirmed that perimenopausal women were working harder just to maintain performance levels, failing to show the learning curve improvements seen in pre- and postmenopausal women. Neuroimaging shows that maintaining cognitive function requires recruiting additional brain regions.

By the time they seek help, they are not failing. They are maintaining performance at a higher cost, and they feel every dollar of it. This phenomenon is often mislabeled as burnout. Burnout can coexist, but it does not explain why a high-performing woman feels cognitively different when nothing external has changed.

Finding the Path Back

The goal of evaluation is not to find a single abnormal number, as there usually isn't one. It is to look for patterns: cognitive changes, sleep quality, energy distribution, vasomotor symptom burden, and subtle metabolic signals. The burden is cumulative.

From this complete picture, treatment is tailored. The primary driver might be sleep, or vasomotor symptoms might be causing more damage than realized. Hormone therapy may be appropriate, considering that initiation closer to menopause onset improves verbal memory outcomes in a way that late-life initiation does not. It is rarely one thing.

The transition is not pathological, but the history of dismissing it is. These women are not vague, fragile, or merely stressed. They are running the world on a depleted system, and they deserve better than to be pushing through. The aim is not to become someone new, but to get back to a familiar version of the effective self.

The Physician's Guide to The Midlife Brain

This is my gift to help you on your journey. Get your copy now.

Dr. Hanah Polotsky is a board-certified endocrinologist and founder of OpExMD, a concierge clinical practice focused on menopause, metabolism, and midlife health optimization for high-performing women. Based in Colorado. Telemedicine consultations for women who live in CO, NY, and NJ at opexmd.com.

---

References

Bangle, A., Williams, D., Walters, J., & Nguyen, L. (2026). Cognitive functioning in perimenopause: An updated systematic review and meta-analysis. Psychology and Aging, 41(3), 303-318. https://doi.org/10.1037/pag0000946

Barth, C., Crestol, A., de Lange, A. G., & Galea, L. A. M. (2023). Sex steroids and the female brain across the lifespan: Insights into risk of depression and Alzheimer's disease. The Lancet. Diabetes & Endocrinology, 11(12), 926-941. https://doi.org/10.1016/S2213-8587(23)00224-3

Caufriez, A., Leproult, R., L'Hermite-Balériaux, M., Kerkhofs, M., & Copinschi, G. (2011). Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism, 96(4), E614-E623. https://doi.org/10.1210/jc.2010-2558

Coborn, J., de Wit, A., Crawford, S., et al. (2022). Disruption of sleep continuity during the perimenopause: Associations with female reproductive hormone profiles. The Journal of Clinical Endocrinology and Metabolism, 107(10), e4144-e4153. https://doi.org/10.1210/clinem/dgac447

Epperson, C. N., Sammel, M. D., & Freeman, E. W. (2013). Menopause effects on verbal memory: Findings from a longitudinal community cohort. Journal of Clinical Endocrinology & Metabolism, 98(9), 3829-3838.

Fogel, J., Rubin, L. H., Kilic, E., Walega, D. R., & Maki, P. M. (2020). Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors. Menopause, 27(11), 1209-1219.

Greendale, G. A., Huang, M. H., Wight, R. G., Seeman, T., Luetters, C., Avis, N. E., Johnston, J., & Karlamangla, A. S. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72(21), 1850-1857.

Haufe, A., Baker, F. C., & Leeners, B. (2022). The role of ovarian hormones in the pathophysiology of perimenopausal sleep disturbances: A systematic review. Sleep Medicine Reviews, 66, 101710. https://doi.org/10.1016/j.smrv.2022.101710

Jacobs, E. G., Weiss, B. K., Makris, N., et al. (2016). Impact of sex and menopausal status on episodic memory circuitry in early midlife. The Journal of Neuroscience, 36(39), 10163-10173. https://doi.org/10.1523/JNEUROSCI.0951-16.2016

Katainen, R., Kalleinen, N., Teperi, S., et al. (2018). The relationship between diurnal cortisol secretion and climacteric-related symptoms. Maturitas, 115, 37-44. https://doi.org/10.1016/j.maturitas.2018.06.007

Khadilkar, S., Mahajan Bhanushali, J., Mahto, A. P., & Khadilkar, S. (2025). Cognition in menopausal women. International Journal of Gynecology and Obstetrics. Advance online publication. https://doi.org/10.1002/ijgo.70944

Lambrinoudaki, I., Paschou, S. A., Armeni, E., & Goulis, D. G. (2022). The interplay between diabetes mellitus and menopause: Clinical implications. Nature Reviews. Endocrinology, 18(10), 608-622. https://doi.org/10.1038/s41574-022-00708-0

Maki, P. M., Drogos, L. L., Rubin, L. H., et al. (2008). Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause, 15(5), 848-856. https://doi.org/10.1097/gme.0b013e31816d815e

Maki, P. M., Wu, M., Rubin, L. H., et al. (2020). Hot flashes are associated with altered brain function during a memory task. Menopause, 27(3), 269-277. https://doi.org/10.1097/GME.0000000000001467

Maki, P. M., Henderson, V. W., & the IMS Menopause and the Brain Working Group. (2022). Brain fog in menopause: A health-care professional's guide for decision-making and counseling on cognition. Climacteric, 25(6), 570-578.

Nappi, R. E., Chedraui, P., Lambrinoudaki, I., & Simoncini, T. (2022). Menopause: A cardiometabolic transition. The Lancet. Diabetes & Endocrinology, 10(6), 442-456. https://doi.org/10.1016/S2213-8587(22)00076-6

Nathan, M. D., Wiley, A., Mahon, P. B., et al. (2020). Hypothalamic-pituitary-adrenal axis, subjective, and thermal stress responses in midlife women with vasomotor symptoms. Menopause, 28(4), 439-443. https://doi.org/10.1097/GME.0000000000001703

Nolan, B. J., Liang, B., & Cheung, A. S. (2021). Efficacy of micronized progesterone for sleep: A systematic review and meta-analysis of randomized controlled trial data. The Journal of Clinical Endocrinology and Metabolism, 106(4), 942-951. https://doi.org/10.1210/clinem/dgaa873

Sauer, T., Tottenham, L. S., Ethier, A., & Gordon, J. L. (2020). Perimenopausal vasomotor symptoms and the cortisol awakening response. Menopause, 27(11), 1322-1327. https://doi.org/10.1097/GME.0000000000001588

Yan, H., Yang, W., Zhou, F., et al. (2019). Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1. Diabetes, 68(2), 291-304. https://doi.org/10.2337/db18-0638